Please enable JavaScript to continue using this application.

Compare $ALDX vs $FRMM | Chartloom

Compare

$ALDX vs $FRMM

Aldeyra Therapeutics Inc · Forum Markets, Inc

ALDX

Aldeyra Therapeutics Inc

FRMM

Forum Markets, Inc

Compare $ALDX vs $FRMM

Comparing Aldeyra Therapeutics Inc and Forum Markets, Inc

ALDXAldeyra Therapeutics Inc

FRMMForum Markets, Inc

ALDXAldeyra Therapeutics Inc

Market cap

$55M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.4%

52W performance

-83.7%

FCF yield

-39.9%

FRMMForum Markets, Inc

Market cap

$59M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.70x

Rev growth (TTM)

—

YTD performance

-12.3%

52W performance

-80.7%

FCF yield

-124.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALDX

FRMM

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

FRMM

Forum Markets, Inc

Market Cap

ALDX$55M

FRMM$59M

Enterprise Value

ALDX$10M

FRMM$59M

Price

ALDX$0.92

FRMM$4.48

P/E Ratio

ALDXN/A

FRMMN/A

P/S Ratio

ALDX0.00x

FRMM5.49x

EV/Sales

ALDX0.00x

FRMM5.49x

EV/EBITDA

ALDX0.00x

FRMM0.00x

P/B Ratio

ALDX1.86x

FRMM0.27x

P/FCF Ratio

ALDXN/A

FRMMN/A

EV/FCF

ALDX-0.46x

FRMM-0.80x

PEG Ratio

ALDXN/A

FRMMN/A

Forward P/E (NTM)

ALDXN/A

FRMMN/A

Forward P/S (NTM)

ALDXN/A

FRMM1.70x

Revenue (TTM)

ALDX$0

FRMM$11M

Revenue Growth (YoY)

ALDXN/A

FRMMN/A

Forward Rev Growth

ALDX298.2%

FRMM132.9%

Gross Margin (TTM)

ALDX0.0%

FRMM3.7%

Operating Margin (TTM)

ALDX0.0%

FRMM0.0%

EBITDA Margin (TTM)

ALDX0.0%

FRMM-122.2%

Net Margin (TTM)

ALDX0.0%

FRMM-4971.8%

FCF Margin (TTM)

ALDXN/A

FRMM-684.9%

Net Income (TTM)

ALDX$-23M

FRMM$-536M

FCF (TTM)

ALDX$-22M

FRMM$-74M

EPS (TTM)

ALDX-$0.38

FRMM-$31.38

ROE (TTM)

ALDX-5314.0%

FRMM-25831.0%

ROA (TTM)

ALDX-3494.0%

FRMM-13469.0%

ROIC (TTM)

ALDX-4205.0%

FRMM-14374.0%

Cash

ALDX$45M

FRMM$0

Debt

ALDX$0

FRMM$0

Net Cash/Debt

ALDX$45M

FRMM$0

Current Ratio (TTM)

ALDX4.91x

FRMM0.33x

Quick Ratio (TTM)

ALDX4.74x

FRMM0.22x

Debt/Equity (TTM)

ALDX0.34x

FRMM0.24x

Debt/Assets (TTM)

ALDX0.0%

FRMM0.0%

Interest Coverage (TTM)

ALDXN/A

FRMMN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

FRMM0.00x

Beta

ALDX1.21

FRMM1.66

52W Performance

ALDX-83.7%

FRMM-80.7%

YTD Performance

ALDX-80.4%

FRMM-12.3%

% from 52W High

ALDX-84.5%

FRMM-81.7%

% from 52W Low

ALDX6.3%

FRMM154.5%

Asset Turnover (TTM)

ALDX0.00x

FRMM0.00x

FCF Yield (TTM)

ALDX-39.9%

FRMM-124.7%

Earnings Yield (TTM)

ALDX-41.7%

FRMM-904.9%

Dividend Yield (TTM)

ALDXN/A

FRMMN/A

Rule of 40

ALDX0.0

FRMM-684.9

EV/GP/RG

ALDXN/A

FRMM0.67

Ticker research

View ALDX research View FRMM research

Metric	ALDX Aldeyra Therapeutics Inc	FRMM Forum Markets, Inc
Market & Valuation
Market Cap	$55M	$59M
Enterprise Value	$10M	$59M
Price	$0.92	$4.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.49x
EV/Sales	0.00x	5.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	0.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.70x
Revenue & Growth
Revenue (TTM)	$0	$11M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	132.9%
Profitability
Gross Margin (TTM)	0.0%	3.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-122.2%
Net Margin (TTM)	0.0%	-4971.8%
FCF Margin (TTM)	N/A	-684.9%
Net Income (TTM)	$-23M	$-536M
FCF (TTM)	$-22M	$-74M
EPS (TTM)	-$0.38	-$31.38
ROE (TTM)	-5314.0%	-25831.0%
ROA (TTM)	-3494.0%	-13469.0%
ROIC (TTM)	-4205.0%	-14374.0%
Financial Health
Cash	$45M	$0
Debt	$0	$0
Net Cash/Debt	$45M	$0
Current Ratio (TTM)	4.91x	0.33x
Quick Ratio (TTM)	4.74x	0.22x
Debt/Equity (TTM)	0.34x	0.24x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	1.66
52W Performance	-83.7%	-80.7%
YTD Performance	-80.4%	-12.3%
% from 52W High	-84.5%	-81.7%
% from 52W Low	6.3%	154.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-124.7%
Earnings Yield (TTM)	-41.7%	-904.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-684.9
EV/GP/RG	N/A	0.67
Ticker research	View ALDX research	View FRMM research

Valuation

P/S Ratio

ALDX

0.00x

FRMM

5.49x

EV/FCF

FRMM

-0.80x

ALDX

-0.46x

Growth & revenue

Forward Revenue Growth

ALDX

298.2%

FRMM

132.9%

Profitability & performance

Gross Margin

FRMM

3.7%

ALDX

0.0%

ROE

ALDX

-5314.0%

FRMM

-25831.0%

FCF Yield %

ALDX

-39.9%

FRMM

-124.7%

52-Week Performance

FRMM

-80.7%

ALDX

-83.7%

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

FRMM

Forum Markets, Inc

Market Cap

ALDX$55M

FRMM$59M

Enterprise Value

ALDX$10M

FRMM$59M

Price

ALDX$0.92

FRMM$4.48

P/E Ratio

ALDXN/A

FRMMN/A

P/S Ratio

ALDX0.00x

FRMM5.49x

EV/Sales

ALDX0.00x

FRMM5.49x

EV/EBITDA

ALDX0.00x

FRMM0.00x

P/B Ratio

ALDX1.86x

FRMM0.27x

P/FCF Ratio

ALDXN/A

FRMMN/A

EV/FCF

ALDX-0.46x

FRMM-0.80x

PEG Ratio

ALDXN/A

FRMMN/A

Forward P/E (NTM)

ALDXN/A

FRMMN/A

Forward P/S (NTM)

ALDXN/A

FRMM1.70x

Revenue (TTM)

ALDX$0

FRMM$11M

Revenue Growth (YoY)

ALDXN/A

FRMMN/A

Forward Rev Growth

ALDX298.2%

FRMM132.9%

Gross Margin (TTM)

ALDX0.0%

FRMM3.7%

Operating Margin (TTM)

ALDX0.0%

FRMM0.0%

EBITDA Margin (TTM)

ALDX0.0%

FRMM-122.2%

Net Margin (TTM)

ALDX0.0%

FRMM-4971.8%

FCF Margin (TTM)

ALDXN/A

FRMM-684.9%

Net Income (TTM)

ALDX$-23M

FRMM$-536M

FCF (TTM)

ALDX$-22M

FRMM$-74M

EPS (TTM)

ALDX-$0.38

FRMM-$31.38

ROE (TTM)

ALDX-5314.0%

FRMM-25831.0%

ROA (TTM)

ALDX-3494.0%

FRMM-13469.0%

ROIC (TTM)

ALDX-4205.0%

FRMM-14374.0%

Cash

ALDX$45M

FRMM$0

Debt

ALDX$0

FRMM$0

Net Cash/Debt

ALDX$45M

FRMM$0

Current Ratio (TTM)

ALDX4.91x

FRMM0.33x

Quick Ratio (TTM)

ALDX4.74x

FRMM0.22x

Debt/Equity (TTM)

ALDX0.34x

FRMM0.24x

Debt/Assets (TTM)

ALDX0.0%

FRMM0.0%

Interest Coverage (TTM)

ALDXN/A

FRMMN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

FRMM0.00x

Beta

ALDX1.21

FRMM1.66

52W Performance

ALDX-83.7%

FRMM-80.7%

YTD Performance

ALDX-80.4%

FRMM-12.3%

% from 52W High

ALDX-84.5%

FRMM-81.7%

% from 52W Low

ALDX6.3%

FRMM154.5%

Asset Turnover (TTM)

ALDX0.00x

FRMM0.00x

FCF Yield (TTM)

ALDX-39.9%

FRMM-124.7%

Earnings Yield (TTM)

ALDX-41.7%

FRMM-904.9%

Dividend Yield (TTM)

ALDXN/A

FRMMN/A

Rule of 40

ALDX0.0

FRMM-684.9

EV/GP/RG

ALDXN/A

FRMM0.67

Ticker research

View ALDX research View FRMM research

Metric	ALDX Aldeyra Therapeutics Inc	FRMM Forum Markets, Inc
Market & Valuation
Market Cap	$55M	$59M
Enterprise Value	$10M	$59M
Price	$0.92	$4.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.49x
EV/Sales	0.00x	5.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	0.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.70x
Revenue & Growth
Revenue (TTM)	$0	$11M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	132.9%
Profitability
Gross Margin (TTM)	0.0%	3.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-122.2%
Net Margin (TTM)	0.0%	-4971.8%
FCF Margin (TTM)	N/A	-684.9%
Net Income (TTM)	$-23M	$-536M
FCF (TTM)	$-22M	$-74M
EPS (TTM)	-$0.38	-$31.38
ROE (TTM)	-5314.0%	-25831.0%
ROA (TTM)	-3494.0%	-13469.0%
ROIC (TTM)	-4205.0%	-14374.0%
Financial Health
Cash	$45M	$0
Debt	$0	$0
Net Cash/Debt	$45M	$0
Current Ratio (TTM)	4.91x	0.33x
Quick Ratio (TTM)	4.74x	0.22x
Debt/Equity (TTM)	0.34x	0.24x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	1.66
52W Performance	-83.7%	-80.7%
YTD Performance	-80.4%	-12.3%
% from 52W High	-84.5%	-81.7%
% from 52W Low	6.3%	154.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-39.9%	-124.7%
Earnings Yield (TTM)	-41.7%	-904.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-684.9
EV/GP/RG	N/A	0.67
Ticker research	View ALDX research	View FRMM research